Lansoprazole-associated microscopic colitis: A case series

American Journal of Gastroenterology

Volumn 97, Issue 11, 2002, Pages 2908-2913

  Thomson, Robert D ^a   Lestina, Lisa S ^a   Bensen, Steven P ^a   Toor, Arifa ^a   Maheshwari, Yogesh ^a   Ratcliffe, Nora R ^a  

^a VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIDEPRESSANT AGENT; CAPTOPRIL; CHLORDIAZEPOXIDE PLUS CLIDINIUM BROMIDE; CISAPRIDE; DESIPRAMINE; DEXTROPROPOXYPHENE; DONNATAL; FAMOTIDINE; FOLIC ACID; FUROSEMIDE; GASTROINTESTINAL AGENT; GEMFIBROZIL; GLIBENCLAMIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCHLOROTHIAZIDE; ISOSORBIDE DINITRATE; ISPAGULA; LANSOPRAZOLE; LISINOPRIL; METOPROLOL; METRONIDAZOLE; NIFEDIPINE; OXAZEPAM; PARACETAMOL; PRAZOSIN; PROTON PUMP INHIBITOR; SERTRALINE; SIMVASTATIN; UNINDEXED DRUG; WARFARIN;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; COLITIS; COLON BIOPSY; COLONOSCOPY; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DRUG INDUCED DISEASE; DRUG SAFETY; DYSPHAGIA; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; TREATMENT OUTCOME;

EID: 0036841773     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2002.07066.x     Document Type: Article

References (27)

1. Langtry HD, Wilde MI. Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders. Drugs 1997;54:473-500.
2. Penson J, Puttemans M, Fourie E, Roussel SA. Safety of lansoprazole in maintenance therapy for reflux oesophagitis. Gut 1995;37(suppl 2):A163.
3. Read N, Krejs G, Read M, et al. Chronic diarrhea of unknown origin. Gastroenterology 1980;78:264-71.
4. Veress B, Lofberg R, Bergman L. Microscopic colitis syndrome. Gut 1995;36:880-6.
5. Lazenby AJ, Yardley JH, Giardiello FM, et al. Lymphocytic ("microscopic") colitis. Hum Pathol 1989;20:18-28.
6. Thomson A. Microscopic colitis - no longer an appropriate term? Am J Gastroenterol 1998;93:524-6.
7. Fernandez-Banares F, Salas A, Forne M, et al. Incidence of collagenous and lymphocytic colitis: A 5-year population based study. Am J Gastroenterol 1999;94:418-23.
8. Mullhaupt B, Guller U, Anabitarte M, et al. Lymphocytic colitis. Clinical presentation and long term course. Gut 1998;43:629-33.
9. Tremaine WJ. Collagenous colitis and lymphocytic colitis. J Clin Gastroenterol 2000;30:245-9.
10. Zins BJ, Sandborn WJ, Tremaine WJ. Collagenous and lymphocytic colitis: Subject review and therapeutic alternatives. Am J Gastroenterol 1995;90:1394-1400.
11. Beaugerie L, Patey N, Brousse N. Ranitidine, diarrhea, and lymphocytic colitis. Gut 1995;37:708-11.
12. Beaugerie L, Luboinski J, Brousse N, et al. Drug induced lymphocytic colitis. Gut 1994;35:426-8.
13. Mahajan L, Wyllie R, Goldblum J. Lymphocytic colitis in a pediatric patient: A possible adverse reaction to carbamazepine. Am J Gastroenterol 1997;92:2126-7.
14. Berrebi D, Sautet A, Flejou JF, et al. Ticlopidine induced colitis: A histological study including apoptosis. J Clin Pathol 1998;51:280-3.
15. Chauveau E, Prignet JM, Carloz E, et al. Lymphocytic colitis likely attributable to use of vinburine. Gastroenterol Clin Biol 1998;22:362.
16. Bouchet-Laneuw F, Deplaix P, Dumollard JM, et al. Chronic diarrhea following ingestion of tardyferon associated with lymphocytic colitis. Gastroenterol Clin Biol 1997;21:83-4.
17. Piche T, Raimondi V, Schneider S, et al. Acarbose and lymphocytic colitis. Lancet 2000;356:1246.
18. Riddell RH, Tanaka M, Mazzoleni G. Non-steroidal antiinflammatory drugs as a possible cause of collagenous colitis: A case control study. Gut 1992;33:683-6.
19. Giardello FM, Hansen FC, Lazenby AJ, et al., Collagenous colitis in setting of non-steroidal anti-inflammatory drugs and antibiotics. Dig Dis Sci 1990;35:257-60.
20. Duncan HD, Talbot IC, Silk DB. Collagenous colitis and cimetidine. Eur J Gastroenterol Hepatol 1997;9:819-20.
21. Wilcox GM, Mattia A. Collagenous colitis associated with lansoprazole. J Clin Gastroenterol 2002;34:164-6.
22. Chagnon JP, Cerf M. Simvastatin-induced protein-losing enteropathy. Am J Gastroenterol 1992;87:257.
23. Freston JW. Long-term acid control and proton pump inhibitors: Interactions and safety issues in perspective. Am J Gastroenterol 1997;92:51-5S.
24. Hatlebakk JG, Berstad A. Lansoprazole 15 and 30 mg daily in maintaining healing and symptom relief in patients with reflux oesophagitis. Aliment Pharmacol Ther 1997;11:365-72.
25. Robinson M, Lanza F, Avner D, et al. Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996;124:859-67.
26. Sontag SJ, Kogut DG, Fleischmann R, et al. Lansoprazole prevents recurrence of erosive esophagitis previously resistant to H2-RA therapy. Am J Gastroenterol 1996;91:1758-65.
27. Gough AL, Long RG, Cooper BT, et al. Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis. Aliment Pharmacol Ther 1996;10:529-39.